13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

34 trials found

diseases per page:

Showing 1 to 10 of 34 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05340985 (ClinicalTrials.gov)	July 2022	2/3/2022	Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis	Investigating the Effects of Hydroxyvitamin D3 Versus Vitamin D3 on Clinical, and Radiologic Progres ...	Multiple Sclerosis, Relapsing-Remitting;Adult ALL;Vitamin D3 Deficiency	Dietary Supplement: 25(OH)D3;Dietary Supplement: vitamin D3	Tehran University of Medical Sciences	Boston University	Not yet recruiting	18 Years	55 Years	All	54	Phase 4	NULL
2	NCT03610139 (ClinicalTrials.gov)	May 21, 2018	13/7/2018	Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple S ...	Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple S ...	Multiple Sclerosis;Multiple Sclerosis, Relapsing-Remitting;Clinically Isolated Syndrome;Clinically I ...	Dietary Supplement: Vitamin D3	American University of Beirut Medical Center	NULL	Recruiting	18 Years	N/A	All	162	N/A	Lebanon
3	NCT03385356 (ClinicalTrials.gov)	December 19, 2017	20/12/2017	Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis	Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis	Multiple Sclerosis, Relapsing-Remitting;Vitamin D Deficiency	Drug: Vitamin D	University Medical Centre Maribor	Medical Faculty Maribor	Completed	18 Years	60 Years	All	89	Phase 4	Slovenia
4	EUCTR2017-004846-31-SI (EUCTR)	14/12/2017	05/12/2017	Vitamin D supplementation in patients with multiple sclerosis	Impact of vitamin D supplementation in patients with multiple sclerosis	Relapsing remitting multiple sclerosis MedDRA version: 20.1;Level: LLT;Classification code 10064137; ...	Trade Name: Oleovit D3 14.400 IU/ml oral drops, solution	University medical centre Maribor	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	95	Phase 4	Slovenia
5	NCT02696590 (ClinicalTrials.gov)	July 2015	18/2/2016	High Dose Oral Versus Intramuscular Vitamin D3 Supplementation In Multiple Sclerosis Patients	Isfahan University of Medical Sciences	Relapsing Remitting Multiple Sclerosis	Dietary Supplement: Vitamin D3	Isfahan University of Medical Sciences	NULL	Completed	23 Years	59 Years	Both	200	N/A	Iran, Islamic Republic of
6	NCT02096133 (ClinicalTrials.gov)	October 13, 2014	21/3/2014	Vitamin D3 and the Stress-axis in MS	Regulation of the Stress-axis by Vitamin D3 in Subjects With Multiple Sclerosis; a Double-blinded, R ...	Multiple Sclerosis	Drug: Cholecalciferol;Other: Placebo comparator	Academic MS Center Limburg	NULL	Terminated	18 Years	N/A	Female	54	Phase 2	Netherlands
7	NCT01817166 (ClinicalTrials.gov)	July 16, 2013	20/3/2013	Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolate ...	Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment Wit ...	Multiple Sclerosis	Drug: Vitamin D;Drug: Placebo;Other: Imaging;Biological: Lumbar puncture;Biological: Blood sampling; ...	Centre Hospitalier Universitaire de Nimes	NULL	Active, not recruiting	18 Years	56 Years	All	316	Phase 3	France
8	NCT01768039 (ClinicalTrials.gov)	March 2013	11/1/2013	Vitamine D in Multiple Sclerosis	Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis	Multiple Sclerosis	Drug: Vitamin D;Drug: Placebo	Mazandaran University of Medical Sciences	NULL	Not yet recruiting	18 Years	50 Years	Both	240	Phase 3	Iran, Islamic Republic of
9	NCT01753375 (ClinicalTrials.gov)	January 2013	17/12/2012	Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis	Role of Vitamin D on the Relapse Rate of Multiple Sclerosis	Multiple Sclerosis	Dietary Supplement: Vitamin D3;Dietary Supplement: Placebo	AlJohara M AlQuaiz, M.D.	NULL	Not yet recruiting	18 Years	55 Years	Both	200	Phase 2	Saudi Arabia
10	NCT01728922 (ClinicalTrials.gov)	November 6, 2012	8/11/2012	Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome ...	Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome ...	Clinically Isolated Syndrome;Multiple Sclerosis	Dietary Supplement: 5000IU vitamin D;Dietary Supplement: 10000IU vitamin D;Other: Placebo	University College Dublin	University of Dublin, Trinity College;St Vincent's University Hospital, Ireland	Completed	18 Years	55 Years	All	64	Phase 1/Phase 2	Ireland

First Previous1 2 3 4Next Last